Viemed Healthcare, Inc. logo VMD - Viemed Healthcare, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 1
HOLD 0
SELL 0
STRONG
SELL 0
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue 270.3 224.3 183.0 138.8 117.1 131.3 80.3 65.3 46.9 31.4 34.6 23.3
Cost of Revenue 114.8 91.1 70.2 54.2 43.7 51.2 24.2 16.7 12.3 12.5 7.8 3.9
Gross Profit 155.5 133.2 112.8 84.7 73.4 80.1 56.0 48.6 34.6 18.9 26.8 19.4
Operating Expenses
R&D Expenses 3.0 3.1 2.8 2.7 2.1 1.1 0.8 0 0 0 0 0
SG&A Expenses 130.5 112.5 93.7 73.4 60.0 57.7 45.3 30.9 20.2 13.8 16.7 9.6
Other Expenses 1.2 (0.2) 1.9 0.4 (0.3) (5.5) 1.0 (0.1) 0.4 0.3 0 0
Operating Expenses 134.7 115.3 98.5 76.4 61.8 53.3 47.1 31.5 20.6 14.1 16.7 9.9
Operating Income
Operating Income 20.7 17.9 14.3 8.3 11.6 26.8 8.9 17.0 8.8 0.4 10.0 9.5
Interest Expense 1.2 0.8 0.4 0.2 0.3 0.5 0.3 0.2 0.3 0.3 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0 0.1 0.0
Profitability
EBITDA 51.6 42.3 36.7 24.8 24.1 36.5 15.5 13.9 11.4 1.8 11.9 9.9
EBIT 22.9 16.9 14.8 9.2 12.8 26.9 9.1 10.1 8.8 0.4 10.9 9.5
Income Before Tax 21.8 16.2 14.4 9.0 12.5 26.4 8.8 10.3 8.2 0.1 10.0 9.5
Income Tax Expense 6.4 4.8 4.1 2.8 3.4 (5.2) 0.3 0.2 0.0 (1.1) 1.0 0
Net Income 14.9 11.3 10.2 6.2 9.1 31.5 8.5 10.2 8.2 1.2 8.9 9.5
Per Share Data
EPS (Basic) 0.38 0.29 0.27 0.15 0.23 0.86 0.23 0.27 0.22 0.03 1.49 1.58
EPS (Diluted) 0.37 0.28 0.25 0.15 0.22 0.82 0.22 0.26 0.22 0.03 1.49 1.58
Shares Outstanding 38.9 38.8 38.4 38.7 39.5 38.7 37.7 37.9 37.9 37.9 6.0 6
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 13.5 17.5 12.8 16.9 28.4 31.0 13.4 10.4 5.1 4.3
Short-Term Investments 0 0 0 0 0 0 0 0 0 0
Net Receivables 25.6 24.9 18.5 15.4 14.7 12.4 11.5 8.8 9.8 4.8
Inventory 5.0 4.3 4.6 3.6 2.5 2.3 1.4 2.9 1.6 1.6
Other Current Assets 4.4 6.1 2.4 3.8 0 0 0 0 0 0
Total Current Assets 48.5 52.9 38.4 39.7 47.3 47.2 27.8 23.0 17.0 11.2
Non-Current Assets
Property, Plant & Equipment 82.4 79.2 76.9 68.4 62.8 55.1 54.8 30.6 20.7 13.5
Goodwill 58.9 33.0 29.8 0 0 0 0 0 0 0
Intangible Assets 1.3 0.8 0.6 0 0 0 0 0 0 0
Long-Term Investments 2.8 2.8 3.9 4.2 2.2 0.7 0.0 0 0 0
Other Non-Current Assets 15.8 0 0.9 1.6 0.9 0.9 0 0 0 0
Total Non-Current Assets 166.4 124.2 116.5 77.3 70.7 65.4 54.8 30.6 20.7 13.5
Total Assets 214.9 177.1 154.9 117.0 118.0 112.6 82.6 53.5 37.7 24.7
Current Liabilities
Account Payables 7.3 5.3 7.4 4.9 5.2 3.3 5.7 5.9 3.4 1.9
Short-Term Debt 2.3 0.4 1.1 0 1.5 1.8 1.8 0 0 0.5
Deferred Revenue 7.5 6.7 6.2 4.6 3.8 3.4 3.3 0.2 5.2 0
Other Current Liabilities 23.9 0 6.5 3.2 2.3 4.5 3.1 (2.1) 0.3 0
Total Current Liabilities 41.1 37.3 32.1 18.9 17.8 23.0 25.9 17.0 13.1 9.2
Non-Current Liabilities
Long-Term Debt 11.3 3.6 6.0 0 4.3 5.8 7.6 0 0 0
Deferred Tax Liabilities 15.8 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0.9 0.8 0.6 0.9 0.8 1.3 2.3 1.1 0 0
Total Non-Current Liabilities 30.4 6.4 8.9 1.1 5.3 7.8 13.0 1.5 0.8 2.6
Total Liabilities 71.4 43.8 41 19.9 23.1 30.9 38.9 18.5 13.9 11.8
Stockholders' Equity
Common Stock 16.9 23.4 18.7 15.1 14.0 9.2 3.4 0.1 0.1 0.1
Retained Earnings 102.9 89.7 79.5 69.8 73.3 65.6 34.1 29.6 21.0 12.8
Accumulated Other Comprehensive Income 0 0 0 0 (0.3) (0.5) (0.2) (8.8) (5.7) 0
Total Stockholders' Equity 141.5 131.4 113.9 97.1 94.8 81.7 43.7 35.0 23.7 12.9
Total Liabilities & Equity 214.9 177.1 154.9 117.0 118.0 112.6 82.6 53.5 37.7 24.7
Debt Metrics
Total Debt 15.9 6.9 10.3 0.7 6.5 11.1 19.5 3.4 5.2 6.5
Net Debt 2.4 (10.7) (2.5) (16.2) (21.9) (19.8) 6.2 (7.0) 0.1 2.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 14.9 11.4 10.2 6.2 9.1 31.5 8.5 10.2 8.2 1.2
Depreciation & Amortization 28.6 25.4 21.9 15.6 11.3 9.6 6.4 3.8 2.5 1.4
Stock-Based Compensation 9.1 6.3 5.8 5.2 5.2 4.9 3.9 2.7 0.8 0
Change in Working Capital (2.3) 0.4 7.8 (10.1) (13.6) (10.2) (9.5) (0.7) (4.9) (0.6)
Other Non-Cash Items (1.6) (0.5) 0.9 9.1 6.6 8.1 9.8 6.5 5.3 4.3
Operating Cash Flow 51.9 39.1 45.2 27.7 22.5 35.1 19.1 22.4 12.0 6.4
Investing Activities
Capital Expenditure (40.0) (37.8) (26.1) (22.9) (19.7) (13.0) (13.4) (6.1) (4.0) (1.7)
Acquisitions (26.3) (3.0) (28.6) (0.1) (0.6) (0.6) 0.6 0.8 0.4 0.7
Purchases of Investments 0 0 0 (2) (0.6) 0 0 0 0 0
Sales/Maturities of Investments 0 0.8 0 0 0.6 0 0 0 0 0
Other Investing Activities 16.2 9.3 2.6 1.1 0.6 5.3 (0.0) 0.8 0.4 0.7
Investing Cash Flow (50.2) (30.7) (52.1) (24.0) (19.7) (8.4) (12.8) (5.3) (3.6) (0.9)
Financing Activities
Net Debt Issuance 8.2 (3.4) 2.1 (5.8) (4.0) (10.9) (2.2) (10.2) (7.7) (4.3)
Stock Repurchased (13.2) (1.1) (0.6) (9.7) (1.4) 0 (1.5) (1.6) 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (2.2) 0.8 1.3 0.3 0.1 1.9 0.4 0.0 0 0
Financing Cash Flow (5.8) (3.7) 2.8 (15.3) (5.3) (9.1) (3.3) (11.8) (7.7) (4.3)
Cash Position
Net Change in Cash (4.0) 4.7 (4.1) (11.5) (2.6) 17.6 2.9 5.3 0.8 1.2
Cash at Beginning 17.5 12.8 16.9 28.4 31.0 13.4 10.4 5.1 4.3 3.1
Cash at End 13.5 17.5 12.8 16.9 28.4 31.0 13.4 10.4 5.1 4.3
Free Cash Flow 11.9 1.3 19.1 4.8 2.8 22.1 5.7 16.3 8.0 4.7
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Income Statement
Revenue 270.3 224.3 183.0 138.8 117.1 131.3 80.3 65.3 46.9 31.4 34.6 23.3
Gross Profit 155.5 133.2 112.8 84.7 73.4 80.1 56.0 48.6 34.6 18.9 26.8 19.4
Operating Income 20.7 17.9 14.3 8.3 11.6 26.8 8.9 17.0 8.8 0.4 10.0 9.5
Net Income 14.9 11.3 10.2 6.2 9.1 31.5 8.5 10.2 8.2 1.2 8.9 9.5
EPS (Diluted) 0.37 0.28 0.25 0.15 0.22 0.82 0.22 0.26 0.22 0.03 1.49 1.58
Balance Sheet
Cash & Equivalents 13.5 17.5 12.8 16.9 28.4 31.0 13.4 10.4 5.1 4.3
Total Assets 214.9 177.1 154.9 117.0 118.0 112.6 82.6 53.5 37.7 24.7
Total Debt 15.9 6.9 10.3 0.7 6.5 11.1 19.5 3.4 5.2 6.5
Stockholders' Equity 141.5 131.4 113.9 97.1 94.8 81.7 43.7 35.0 23.7 12.9
Cash Flow
Operating Cash Flow 51.9 39.1 45.2 27.7 22.5 35.1 19.1 22.4 12.0 6.4
Capital Expenditure (40.0) (37.8) (26.1) (22.9) (19.7) (13.0) (13.4) (6.1) (4.0) (1.7)
Free Cash Flow 11.9 1.3 19.1 4.8 2.8 22.1 5.7 16.3 8.0 4.7